Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)

Clinical trial NCT03234114 · UNKNOWN

Trial details

NCT number: NCT03234114
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Coronary Syndrome (ACS)Non-valvular Atrial Fibrillation (NVAF)

Start date: 2018-02-03
Primary completion: 2024-12-31
Enrollment: 3746

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.